PIK3CA and urinary bladder cancer: No matter the mechanism though, the fact that TTI1 (28%) is overexpressed and kinase-PIK3Ca signaling (72%) is altered in a significant number of bladder cancer cases indicates that reducing the chaperone activity that supports this axis may be viable approach to treating MIBC [7].